公司資料
Vanda Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- VNDA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
5.28 USD (-1.86%)
收盤價
最後更新: 2026年8月21日
369M USD
市值
股價為何變動
As of Aug 21, 2026, VNDA closed down 1.86% at $5.28. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Vanda Pharmaceuticals is a specialty pharma company with an emphasis on neuroscience and sleep-related therapies. Its business has long centered on commercial products and selective pipeline development.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Vanda sits in specialty biopharma.
商業模式特徵
The company depends on product revenue, label positioning, and the ability to build new assets around a concentrated commercial base.
生技產業定位
Vanda is a commercial specialty-pharma name whose valuation is tied to product durability and pipeline optionality.
未來催化劑
- Vanda’s catalysts are HETLIOZ and Fanapt execution, plus any regulatory or litigation update tied to the sleep franchise. The stock usually moves when the company shows that the commercial base can stay durable.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。